Related Experiment Video
Updated: Mar 21, 2026

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats
Published on: March 28, 2025
[Clinical and etiological profile malignant hypertension in children in pediatric intensive care]
D-D Batouche1, K E Kerboua2, L Sadaoui3
1Service de réanimation pédiatrique CHU d'Oran, Oran, Algérie.
Insights
Malignant hypertension (mHTA) is a rare but serious condition in children, often secondary to kidney issues. Early intensive care is crucial for managing severe hypertension and its organ-damaging effects in pediatric patients.
Area of Science:
- Pediatric Nephrology
- Pediatric Critical Care
- Cardiovascular Research
Background:
- Malignant hypertension (mHTA) in pediatrics presents uniquely with severe hypertension and organ damage.
- It is a rare condition with significant implications for vital organ function in children.
Purpose of the Study:
- To investigate the prevalence, clinical presentation, and outcomes of malignant hypertension in a pediatric intensive care setting.
- To identify common causes and clinical signs associated with mHTA in children.
Main Methods:
- A retrospective study analyzed pediatric intensive care cases over two 10-year periods (1994-2004 and 2005-2015).
- Cases of malignant hypertension (mHTA) were identified and analyzed for demographic, clinical, and outcome data.
Main Results:
- Sixty-six pediatric patients with mHTA were identified, a prevalence of 0.6%, with ages ranging from 12 months to 16 years.
- Common manifestations included hypertensive convulsive encephalopathy (33.3%), renal disease, and severe retinopathy (stage 3/4 in 47%/51%).
- Average blood pressure readings were 175mmHg systolic and 112.5mmHg diastolic; mHTA was frequently secondary to renal causes.
Conclusions:
- Malignant hypertension is a rare pediatric condition characterized by severe hypertension impacting vital organs.
- Early diagnosis and intensive care support are essential for managing pediatric mHTA and improving patient outcomes.
- The study highlights the importance of addressing underlying causes, particularly renal disease, in pediatric mHTA.
Introduction:
Malignant hypertension (HTA), pediatrics, is unique by its clinical presentation, defined as severe hypertension accompanied by ischemic failure of one or more organs.
Methods-Patients:
Retroprospective study of cases of children admitted to pediatric intensive care. We chose a decline of 10 years from September 1994 to December 2004 for the first time, and from January 2005 to December 2015 for the second period; and we identified the cases presenting malignant hypertension (mHTA).
Results:
Sixty-six patients were included, a prevalence of 0.6%. The age of patients ranged from 12months to 16years. The symptoms are related to the consequences of hypertension or condition in question. The most found signs are headache in more than 7%. Cerebrovascular event in 6%. A hypertensive convulsive encephalopathy 33.3% of patients. Renal disease is common, of varying severity. A fundus retinopathy was found in 47% stage 3, stage 4 in 51%. mHTA defined for the mean SBP values of 175mmHg and DBP average 112,5mmHg is often secondary to renal causes. The treatment is symptomatic with antihypertensive associated with the etiological treatment. Evolution is good out of 7 deaths.
Conclusion:
mHTA is a rare condition in the pediatric population. The clinical signs of functional rich under their impact on vital organs. The support must be early in intensive care.
More Related Videos
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension I: Introduction
Hypertension and Regulation of Blood Pressure
Hypertension V: Nursing Management
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Hypertension II: Pathophysiology

